The NGI Next Generation Impactor provides accurate particle size distribution data for inhalation product development and aerosol research. Engineered for high reproducibility and compliance with regulatory standards, the NGI Next Generation Impactor ensures reliable performance for pharmaceutical testing, quality control, and detailed aerosol characterization.
- Compliant with ISO 27427, USP (United States Pharmacopeia) and PhEur (European Pharmacopeia)
- Features an 8-stage collection system, comprising 7 stages along with a Micro-Orifice Collector (MOC).
- Offers precise cut points for accurate particle size determination.
- Abundance of accessories designed to enhance testing efficiency.
- Conducts in vitro Aerodynamic Particle Size Distribution (APSD) testing contrary to Standard Andersen Cascade Impactor 8 Stages.
- Exhibits corrosion and chemical resistance for robust durability.
- Extended equipment life for prolonged and reliable usage.
- Incorporates a Micro-Orifice Collector (MOC) for the collection of exceptionally small particles, adding a unique dimension to particle analysis capabilities.
| Weight | (kg) 18 |
| Stages | 7 + MOC (internal filter, external filter, induction port and pre-separator are not included) |
| Calibrated flow rate | 15 L/min – 100 L/min |
| Lid | Anodized Aluminium |
| Seal body | Anodized Aluminium |
| Nozzles | Stainless Steel |
| Cups | Stainless Steel (2 large, 6 small) |
| Bottom Frame | Anodized Aluminium |
- Pharmaceutical: Inhaler testing (APSD)
- In-vitro testing in inhalation/pharmaceutical sector
- Production (OINDP)
- Efficiency (OINDP)
- Healthcare
